An overview of chromatographic methods coupled with mass spectrometric detection for determination of angiotensin-converting enzyme inhibitors in biological material

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 2, 2007, Pages 356-367

  Rudzki, Piotr J ^a   Buś, Katarzyna ^a   Ksycińska, Hanna ^a   Kobylińska, Kamila ^a  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors and their metabolites; Bioanalysis; Biological material; Gas chromatography mass spectrometry (GC MS); Liquid chromatography mass spectrometry (LC MS)

Indexed keywords

BENAZEPRIL; BENAZEPRILAT; BIOMATERIAL; CAPTOPRIL; CIS TRANS ISOMERASE; DELAPRIL; DIAZOMETHANE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; ENALAPRIL; ENALAPRILAT; FOSINOPRIL; FOSINOPRILAT; IMIDAPRIL; LISINOPRIL; MANIDIPINE; MOEXIPRIL; MOEXIPRILAT; PERINDOPRIL; PERINDOPRILAT; QUINAPRIL; QUINAPRILAT; RAMIPRIL; RAMIPRILAT; SPIRAPRIL; SPIRAPRILAT; TEMOCAPRIL; TEMOCAPRILAT; ZOFENOPRIL; ZOFENOPRILAT;

ARTICLE; BLOOD ANALYSIS; CHEMICAL STRUCTURE; CHROMATOGRAPHY; CIS TRANS ISOMERISM; DRUG DETERMINATION; DRUG STABILITY; HUMAN; IONIZATION; ISOMERIZATION; MASS SPECTROMETRY; MEDICAL LITERATURE; METABOLITE; PLASMA; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; URINALYSIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY FLUIDS; CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MASS SPECTROMETRY; REFERENCE STANDARDS; STEREOISOMERISM;

EID: 34249932511     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.03.018     Document Type: Article

References (96)

1. Kubo S.H., and Cody R.J. Clin. Pharmacokinet. 10 (1985) 377-391
2. Kelly J.G., and O'Malley K. Clin. Pharmacokinet. 19 (1990) 177-196
3. Song J.C., and White M. Clin. Pharmacokinet. 41 (2002) 207-224
4. Reid I.A. Arch. Intern. Med. 145 (1985) 1475-1479
5. Saunders J. Top Drugs: Top Synthetic Routes (2000), Oxford University Press pp.1-15
6. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, http://www.whocc.no/atcddd/.
7. Sioufi A., Pommier F., Kaiser G., and Dubois J.P. J. Chromatogr. 434 (1988) 239-246
8. Pommier F., Boschet F., and Gosset G. J. Chromatogr. B 783 (2003) 199-205
9. Xiao W., Chen B., Yao S., and Cheng Z. J. Chromatogr. B 814 (2005) 303-308
10. Vonaparti A., Kazanis M., and Panderi I. J. Mass Spectrom. 41 (2006) 593-605
11. Funke P.T., Ivashkiv E., Malley M.F., and Cohen A.I. Anal. Chem. 52 (1980) 1086-1089
12. Cohen A.I., Devlin R.G., Ivashkiv E., Funke P.T., and McCormick T. J. Pharm. Sci. 71 (1982) 1251-1256
13. Matsuki Y., Ito T., Fukuhara K., Nakamura T., Kimura M., and Ono H. J. Chromatogr. 239 (1982) 585-594
14. Ivashkiv E., McKinstry D.N., and Cohen A.I. J. Pharm. Sci. 73 (1984) 1113-1117
15. Cohen A.I., Ivashkiv E., McCormick T., and McKinstry D.N. J. Pharm. Sci. 73 (1984) 1493-1495
16. Leis H.J., Leis M., Welz W., and Malle E. J. Chromatogr. 529 (1990) 299-308
17. Salem I.I., Saif W.A., Jmeian Y., and Al-Tamimi J.I. J. Pharm. Biomed. Anal. 37 (2005) 1073-1080
18. Franklin M.E., Addison R.S., Baker P.V., and Hooper W.D. J. Chromatogr. B 705 (1998) 47-54
19. Stockis A., Gengler C., Goethals F., Jeanbaptiste B., Lens S., Poli G., and Acerbi D. Arzein. -Forsch./Drug Res. 53 (2003) 627-634
20. Maya M.T., Goncalves N.J., Silva N.E., Filipe A.E.P., Morais J.A., Caturla M.C., and Rovira M. Eur. J. Drug Metab. Ph. 27 (2002) 91-99
21. Niopas I., Daftsios A.C., and Nikolaidis N. Int. J. Clin. Pharmacol. Ther. 41 (2003) 226-230
22. Gu Q., Chen X., Zhong D., and Wang Y. J. Chromatogr. B 813 (2004) 337-342
23. Pisarev V.V., Moskaleva N.E., Zverkov Yu.B., Smirnova L.B., Belolipetskaya V.G., and Sukhanov Ya.V. Pharmaceut. Chem. J. 39 (2005) 104-107
24. Jemal M., Huang M., Mao Y., Whigan D., and Schuster A. Rapid Commun. Mass Spectrom. 14 (2000) 1023-1028
25. Jemal M., and Mulvana D.E. J. Chromatogr. B: Biomed. Sci. Appl. 739 (2000) 255-271
26. Matsuoka M., Horimoto S., Mabuchi M., and Banno K. J. Chromatogr. 581 (1992) 65-73
27. Mabuchi M., Kano Y., Fukuyama T., and Kondo T. J. Chromatogr. B 734 (1999) 145-153
28. Yun J.H., Myung J.H., Kim H.J., Lee S., Park J.-S., Kim W., Lee E.-H., Moon C.J., and Hwang S.-J. Arch. Pharm. Res. 28 (2005) 463-468
29. Leis H.J., Fauler G., Raspotnig G., and Windischhofer W. Rapid Commun. Mass Spectrom. 13 (1999) 650-653
30. Tsakalof A., Bairachtari K., and Georgarakis M. J. Chromatogr. B 783 (2003) 425-432
31. Tashtoush B.M., Alali F.Q., and Najib N.M. Pharmazie 59 (2004) 21-24
32. Padua A.A., Barrientos-Astigarraga R.E., Rezende V.M., Mendes G.D., and De Nucci G. J. Chromatogr. B 809 (2004) 211-216
33. Koytchev R., Ozalp Y., Erenmemisoglu A., van der Meer M.J., and Alpan R.S. Arzneim. -Forsch./Drug Res. 54 (2004) 605-610
34. Tamimi J.J., Salem I.I., Alam S.M., Zaman Q., and Dham R. Biopharm. Drug Dispos. 26 (2005) 335-339
35. Huang J., Xu Y., Liu F., Gao S., and Guo Q. Rapid Commun. Mass Spectrom. 20 (2006) 248-252
36. Hammes W., Hammes B., Buchsler U., Paar F., and Bokens H. J. Chromatogr. B 670 (1995) 81-89
37. Deepak S.J., Subbaiah G., Sanyal M., Pande U.C., and Shrivastav P. J. Chromatogr. B 837 (2006) 92-100
38. Goto N., Kamata T., and Ikegami K. J. Chromatogr. Biomed. Appl. 578 (1992) 195-201
39. Goto N., Sato T., Shigetoshi M., and Ikegami K. J. Chromatogr. Biomed. Appl. 578 (1992) 203-206
40. Kobylińska K., Sobik B., Rudzki P.J., and Ksycińska H. Poster No.: 150 on The XXVIIIth Symposium "Chromatographic Methods of Investigating the Organic Compounds". June 7-9, Katowice-Szczyrk, Poland (2004)
41. Zhu Z., Vachareau A., and Neirinck L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 779 (2002) 297-306
42. Persson B.A., Fakt C., Ervik M., and Ahnoff M. J. Pharm. Biomed. Anal. 40 (2006) 794-798
43. Lu X.Y., Shen-Tu J.Z., and Liu J. J. Pharm. Biomed. Anal. 40 (2006) 478-483
44. Schurer M., Amschler S., Schulz H.-U., and Schafer H. Arzneim.-Forsch./Drug Res. 53 (2003) 307-313
45. Shioya H., Simajo M., and Kawahara Y. J. Chromatogr. Biomed. Appl. 496 (1989) 129-135
46. Dal Bo L., Mazzucchelli P., and Marzo A. J. Chromatogr. B: Biomed. Sci. Appl. 749 (2000) 287-294
47. Leis H.J., Fauler G., Raspotnig G., and Windischhofer W. Rapid Commun. Mass Spectrom. 12 (1998) 1591-1594
48. Ondetti M.A. Circulation 77 (1988) 174-178
49. Cendrowska I., Bankowski K., and Iskra-Jopa J. Acta Pol. Pharm. 60 (2003) 141-144
50. Kocijan A., Grahek R., Kocjan D., and Zupancic-Kralj L. J. Chromatogr. B 755 (2001) 229-235
51. Skoglof A., Nilsson I., Gustafsson S., Deinum J., and Gothe P.O. Biochim. Biophys. Acta 1041 (1990) 22-30
52. Brittain H.G., Morris K.R., Bugay D.E., Thakur A.B., and Serajuddin A.T. J. Pharm. Biomed. Anal. 11 (1993) 1063-1069
53. Swanson B.N., Stauber K.L., Alpaugh W.C., and Weinstein S.H. Anal. Biochem. 148 (1985) 401-407
54. Reydel-Bax P., Redalieu E., and Rakhit A. Clin. Chem. 33 (1987) 549-553
55. Shepley K., Rocci Jr. M.L., Patrick H., and Mojaverian P. J. Pharm. Biomed. Anal. 6 (1988) 241-251
56. Eckert H.G., Munscher G., Oekonomopulos R., Strecker H., Urbach H., and Wissmann H. Arzneimittelforschung 35 (1985) 1251-1256
57. Duncan F.M., Martin V.I., Williams B.C., Al-Dujaili E.A., and Edwards C.R. Clin. Chim. Acta. 131 (1983) 295-303
58. Hossein-Nia M., Surve A.H., Weglein R., Gerbeau C., and Holt D.W. Ther. Drug Monit. 14 (1992) 234-242
59. Tu J.I., Brennan J., Stouffer B., and Eckelman W.C. Ther. Drug Monit. 12 (1990) 404-410
60. Doucet L., De Veyrac B., Delaage M., Cailla H., Bernheim C., and Devissaguet M. J. Pharm. Sci. 79 (1990) 741-745
61. van den Berg H., Resplandy G., de Bie A.T., Floor W., Bertrand M., and Arts C.J. J. Pharm. Biomed. Anal. 9 (1991) 517-524
62. Jankowski A., Skorek A., Krzysko K., Zarzycki P.K., Ochocka R.J., and Lamparczyk H. J. Pharm. Biomed. Anal. 13 (1995) 655-660
63. Sypniewski S., and Bald E. J. Chromatogr. A 729 (1996) 335-340
64. Bald E., Sypniewski S., Drzewoski J., and Stepien M. J. Chromatogr. B: Biomed. Appl. 681 (1996) 283-289
65. Abbara C., Aymard G., Hind S., and Diquet B. J. Chromatogr. B 766 (2002) 199-207
66. Klein J., Colin P., Scherer E., Levy M., and Koren G. Ther. Drug Monit. 12 (1990) 105-110
67. Li K., Tan L., and Zhou J.A. Biomed. Chromatogr. 10 (1996) 237-239
68. Ito H., Yasumatsu M., and Usui Y. Fukuoka Igaku Zasshi. 76 (1985) 441-450
69. Tache F., Farca A., Medvedovici A., and David V. J. Pharm. Biomed. Anal. 28 (2002) 549-557
70. Kok R.J., Visser J., Moolenaar F., de Zeeuw D., and Meijer D.K. J. Chromatogr. B: Biomed. Sci. Appl. 693 (1997) 181-189
71. Tagawa K., Hayashi K., Mizobe M., and Noda K. J. Chromatogr. 617 (1993) 95-103
72. Sagirli O., and Ersoy L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 809 (2004) 159-165
73. Al-Majed A.A., and Al-Zehouri J. Farmaco 56 (2001) 291-296
74. Shimada K., Tanaka M., Nambara T., Imai Y., Abe K., and Yoshinaga K. J. Chromatogr. 227 (1982) 445-451
75. Wakabayashi H., Yamato S., Nakajima M., and Shimada K. J. Pharm. Biomed. Anal. 12 (1994) 1147-1152
76. Belal F., Al-Zaagi I.A., and Abounassif M.A. J. AOAC Int. 84 (2001) 1-8
77. al-Majed A.A., Belal F., Abadi A., and al-Obaid A.M. Farmaco 55 (2000) 233-238
78. Singhvi S.M., Foley J.E., Willard D.A., and Morrison R.A. J. Pharm. Sci. 79 (1990) 970-973
79. Perez-Ruiz T., Martinez-Lozano C., and Galera R. Electrophoresis 27 (2006) 2310-2316
80. van Elswijk D.A., Diefenbach O., van der Berg S., Irth H., Tjaden U.R., and van der Greef J. J. Chromatogr. A 1020 (2003) 45-58
81. National Library of Medicine, National Institutes of Health http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed.
82. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019-3030
83. Annesley T.M. Clin. Chem. 49 (2003) 1041-1044
84. Taylor P.J. Clin. Biochem. 38 (2005) 328-334
85. Souverain S., Rudaz S., and Veuthey J.L. J. Chromatogr. A 1058 (2004) 61-66
86. Fu I., Woolf E.J., and Matuszewski B.K. J. Pharm. Biomed. Anal. 18 (1998) 347-357
87. Dams R., Huestis M.A., Lambert W.E., and Murphy C.M. J. Am. Soc. Mass Spectrom. 14 (2003) 1290-1294
88. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, FDA, CDER, CVM. May 2001.
89. Burinsky D.J., and Sides S.L. J. Am. Soc. Mass Spectrom. 15 (2004) 1300-1314
90. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, Committee for Proprietary Medicinal Products (CPMP), London, July 26, 2001.
91. Shionoiri H., Naruse M., Minamisawa K., Ueda S., Himeno H., Hiroto S., and Takasaki I. Clin. Pharmacokinet. 32 (1997) 460-480
92. Goa K.L., Haria M., and Wilde M.I. Drugs 53 (1997) 1081-1105
93. Schurer M., Erb K., Junge K., Schafer H.F., Schulz H.U., Amschler S., Krupp S., and Hermann R. Arzneimittelforschung 53 (2003) 414-419
94. Puchler K., Sierakowski B., and Roots I. Br. J. Clin. Pharmacol. 46 (1998) 363-367
95. Marzo A., Dal Bo L., Mazzucchelli P., Monti N.C., Crivelli F., Ismaili S., Giusti A., and Uhr M.R. Arzneimittelforschung 52 (2002) 233-242
96. Maurer H.H., Kraemer T., and Arlt J.W. Ther. Drug Monit. 20 (1998) 706-713